There is no website visitor data available for this stock.
---
TTNP FAQ
What was Titan Pharmaceuticals’s price range in the past 12 months?
Titan Pharmaceuticals lowest stock price was $5.00 and its highest was $16.60 in the past 12 months.
What is Titan Pharmaceuticals’s market cap?
Currently, no data Available
When is Titan Pharmaceuticals’s upcoming earnings report date?
Titan Pharmaceuticals’s upcoming earnings report date is Nov 11, 2024 which is in 200 days.
How were Titan Pharmaceuticals’s earnings last quarter?
Titan Pharmaceuticals released its earnings results on Nov 13, 2023. The company reported -$0.022 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.022.
Titan Pharmaceuticals does not currently pay dividends.
What is Titan Pharmaceuticals’s EPS estimate?
Titan Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Titan Pharmaceuticals have?
Titan Pharmaceuticals has 914,234 shares outstanding.
What happened to Titan Pharmaceuticals’s price movement after its last earnings report?
Titan Pharmaceuticals reported an EPS of -$0.022 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -7.032%.
Which hedge fund is a major shareholder of Titan Pharmaceuticals?
Currently, no hedge funds are holding shares in TTNP
Titan Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in development of therapeutics for the treatment of medical disorders. Its products include Probuphine, Ropinirole Implant, and T3 Implant. The company was founded by Louis R. Bucalo in February 7, 1992 and is headquartered in South San Francisco, CA.